Search results
Moderna says next-gen COVID shot effective in study
BioPharma Dive via Yahoo Finance· 6 days agoTrial data suggest the shot — an important component of an upcoming combination inoculation — has proven at least as effective, and in some cases...
Kansas sues Pfizer over 'misrepresentations' and 'adverse events' of COVID-19 vaccine
FOX Business· 2 days agoThe State of Kansas has filed a lawsuit against Pfizer, Inc. for alleged consumer protection...
Kansas sues Pfizer over ‘misleading statements’ about COVID vaccine
The Hill via Yahoo News· 1 day agoThe state of Kansas filed a lawsuit Monday against pharmaceutical company Pfizer, alleging the...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 7 days agoThat compares to 55.6% for Keytruda alone. Earlier in the year, one analyst called results from the...
Gateway - The Root
The Root· 1 day agoThe booster shot should come eight months after the second shot; officials also said that people who got the one-shot Johnson and Johnson vaccine will also ...
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 5 days agoThe CDC advises that everyone ages 5 and older should get one dose of one of the current COVID ...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 5 days agoShares now have a top Relative Strength Rating of 99. The RS Rating pits all stocks, regardless of...
COVID cases rising in L.A. County and California as new subvariants make mark
Los Angeles Times· 6 days agoCalifornia’s COVID-19 numbers are on the rise thanks in part to new subvariants, suggesting an...
A new Alzheimer's drug, combined COVID and flu vaccine update, and salmonella concerns. 3 health...
Yahoo Life Style via AOL· 4 days agoModerna's combo shot wins over separate ones Moderna’s latest medical innovation is packing a one...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 7 days agoThe company also unveiled promising results in...Pfizer is competing against GSK's Arexvy, which hit...
